Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites
The World Health Organization estimates the number of people suffering from depression to be over 264 million. Current monoamine transmission modulating therapeutics, even with proper adherence and acceptable tolerability, are not effective for nearly one third of the patients, leading clinicians to...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393507/ https://www.ncbi.nlm.nih.gov/pubmed/32732918 http://dx.doi.org/10.1038/s41598-020-69773-7 |